what bmi is needed for glp 1 Do You Need to Qualify Semaglutide GLP-1? The Promise of Injectable GLP-1

Clinical trials have shown that WEGOVY leads to greater weight loss compared to other treatments, including Eli Lillys ZEPBOUND , reinforcing its position as a top obesity treatment

Novo Nordisk has added ileus to the Postmarketing Experience section of the Wegovy label under Gastrointestinal Disorders. In October 2025, Severe Gastrointestinal Adverse Reactions was added to the WARNING AND PRECAUTIONS section of the label

[PubMed] [Google Scholar] 54.Drucker DJ, Lee YC, Asa SL, Brubaker PL

Research shows approximately 2530% of GLP-1 users experience nausea, vomiting, or constipationsymptoms that can be worsened by stimulants

While the medication starts working as soon as its administered, significant appetite reduction usually takes a few days to weeks